These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 3322341

  • 21. Evaluation of typhoid vaccines: primary immunization.
    Boparai MS, Murthy RG, Varma RN.
    Indian J Med Res; 1973 Jun; 61(6):802-17. PubMed ID: 4754325
    [No Abstract] [Full Text] [Related]

  • 22. Cellular immunity against Salmonella typhi after live oral vaccine.
    Nencioni L, Villa L, De Magistris MT, Romano M, Boraschi D, Tagliabue A.
    Adv Exp Med Biol; 1987 Jun; 216B():1669-75. PubMed ID: 3501237
    [No Abstract] [Full Text] [Related]

  • 23. Salmonella typhi and Salmonella paratyphi antibodies in Kenya.
    Jumba MM, Mirza NB, Mwaura FB.
    East Afr Med J; 1995 Dec; 72(12):755-7. PubMed ID: 8689970
    [Abstract] [Full Text] [Related]

  • 24. [Immunochemical study of the antigenic complexes from typhoid-paratyphoid A and B bacteria obtained industrially].
    Khatuntseva NV, Mironova MV, Riapolova RG, Rybasova GV.
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):50-5. PubMed ID: 4409774
    [No Abstract] [Full Text] [Related]

  • 25. The immunizing capacity of a five years old dried typhoid vaccine.
    Dimache G, Dimache V, Croitoru M.
    Arch Roum Pathol Exp Microbiol; 1981 Jun; 40(1):55-9. PubMed ID: 7185349
    [No Abstract] [Full Text] [Related]

  • 26. Further studies of protective activity of antigen complexes of typhoid and paratyphoid B vaccines.
    Hejfec LB, Stanislavskij ES, Levina LA.
    Prog Immunobiol Stand; 1971 Jun; 5():389-93. PubMed ID: 4573947
    [No Abstract] [Full Text] [Related]

  • 27. Impairment of immunogenicity of Salmonella typhi Ty21a due to pre-existing cross-reacting intestinal antibodies.
    Forrest BD.
    Adv Exp Med Biol; 1995 Jun; 371B():1649-52. PubMed ID: 7502875
    [No Abstract] [Full Text] [Related]

  • 28. Enteric fever in Israel travelers: a nationwide study.
    Arya SC, Agarwal N.
    J Travel Med; 2006 Jun; 13(5):327; author reply 328. PubMed ID: 16987137
    [No Abstract] [Full Text] [Related]

  • 29. Human cell mediated immunity to porins from Salmonella typhi.
    Blanco F, Isibasi A, Raúl González C, Ortiz V, Paniagua J, Arreguín C, Kumate J.
    Scand J Infect Dis; 1993 Jun; 25(1):73-80. PubMed ID: 8384733
    [Abstract] [Full Text] [Related]

  • 30. Immunisation against cholera with a Ty21a-cholera hybrid.
    La Brooy JT, Forrest B, Bartholomeusz C.
    Ann Sclavo Collana Monogr; 1986 Jun; 3(1-2):143-7. PubMed ID: 3426872
    [No Abstract] [Full Text] [Related]

  • 31. Salmonella enterica serovar Typhimurium strain lacking pmrG-HM-D provides excellent protection against salmonellosis in murine typhoid model.
    Negi VD, Singhamahapatra S, Chakravortty D.
    Vaccine; 2007 Jul 20; 25(29):5315-23. PubMed ID: 17574312
    [Abstract] [Full Text] [Related]

  • 32. Impairment of immunogenicity of Salmonella typhi Ty21a due to preexisting cross-reacting intestinal antibodies.
    Forrest BD.
    J Infect Dis; 1992 Jul 20; 166(1):210-12. PubMed ID: 1607701
    [No Abstract] [Full Text] [Related]

  • 33. Multi-epitope DnaK peptide vaccine accords protection against lethal S. typhimurium challenge: Elicits both cell mediated immunity and long-lasting serum-neutralizing antibody titers.
    Verma S, Singh K, Bansal A.
    Pharmacol Res; 2021 Jul 20; 169():105652. PubMed ID: 33975015
    [Abstract] [Full Text] [Related]

  • 34. Typhoid-paratyphoid (TAB) vaccine as interferon inducer in mice.
    Kandefer-Szerszeń M.
    Acta Microbiol Pol A; 1973 Jul 20; 5(3):156-62. PubMed ID: 4358715
    [No Abstract] [Full Text] [Related]

  • 35. Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica Serovar Typhi strains used as live oral vaccines in humans.
    Sztein MB.
    Clin Infect Dis; 2007 Jul 15; 45 Suppl 1():S15-9. PubMed ID: 17582562
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Cutting edge: role of B lymphocytes in protective immunity against Salmonella typhimurium infection.
    Mittrücker HW, Raupach B, Köhler A, Kaufmann SH.
    J Immunol; 2000 Feb 15; 164(4):1648-52. PubMed ID: 10657605
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.